@AnthonyInfanto3 @Y12 @Luigimoro I hope for years until median is reached but data should be measured against the ~30weeks seen with $ADAP / $GSK NY-ESO-1 SPEAR T-cells https://t.co/pbKnWGBZH5
3,940 followers
207 followers
@pick1998_2 An NY-ESO-1 TCR-T has shown an ORR of 50% and mDOR of 30.9 weeks in some advanced sarcoma patients https://t.co/92siX7Yqad $GSK has four additional programs (with $ADAP and two with $LYEL) which should improve the depth and duration of respons
85 followers
RT @dhovekamp42: $GSK $ADAP "... successful infiltration of solid tumors by SPEAR T cells, which are able to kill tumor cells. Our data al…
4,044 followers
RT @jitcancer: Exciting data for TCR T cells in synovial #sarcoma #ASCO21 Learn more on affinity engineered TCR T cells from #JITC archives…